Navigation Links Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT

IRVINE, Calif., April 23 /PRNewswire/ -- announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles and opinions on the subject and sector.

Investors can view MarketStats by visiting: -- a division of financial news hub

Today's MarketStats on diagnostic companies include: Kraig Biocraft Laboratories, Inc. (OTC Bulletin Board: KBLB), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Bio-Reference Laboratories Inc. (NasdaqGS: BRLI) and Abbott Laboratories (NYSE: ABT).

To view a complete profile on Kraig Biocraft Laboratories, Inc. visit

Visit SectorWatch's parent site for a Biotechnology message board and to read or contribute articles on the subject. Users are invited to post editorials and messages on the website. Intelligent articles submitted through the site will be posted as Member Editorials for review by the investing public. - research-therapeutics-discovery (Please copy and paste into your web browser)

MarketStats provide snapshots and analysis on public equities making news, driving industry sectors and affecting the markets. is powered by Market Pathways, a leader in the representation of Small Cap equities for over twenty-five years and your discovery zone for under-followed stocks emerging in the market.

Interested investors may subscribe to our StockUpTicks newsletter featuring a treasure trove of promising companies, daily market movers and free personal investment information -- visit D.R. Clark of Market Pathways is a member of the National Association of Securities Dealers, CRD # 4518163.

Contact us directly to have your company featured in or For D.R. Clark's perspective on personal finance and the markets visit

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. and are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report.

This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. MP has been paid thirty thousand dollars by Kraig Biocraft Laboratories, Inc. for preparation and distribution of this report and other services over a ninety day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
2. Pharmos Issues Letter to Shareholders
3. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
4. HHS Issues First Department-Wide Report on Personalized Health Care
5. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
6. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
7. CCPM Issues Statement on FDAs GIVE Initiative
8. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
9. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):